Y-Intercept (HK)
IRMD icon

Y-Intercept (HK)’s iRadimed IRMD Stock Holding History

Y-Intercept (HK)’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.22M Sell
14,171
-9,446
-40% -$849K 0.03% 900
2026
Q2 		$2.26M Buy
23,617
+20,147
+581% +$1.83M 0.04% 634
2026
Q1 		$334K Buy
+3,470
New +$347K 0.01% 1356
2024
Q3 		– Sell
-9,535
Closed -$419K – 1550
2024
Q2 		$419K Buy
+9,535
New +$406K 0.02% 896

Other funds holding IRMD

Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Davidson Capital Management
Davidson Capital Management Corpus Christi, Texas $604M AUM 18.09% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Y-Intercept (HK)'s IRMD Position: Q3 2026 in Review

Y-Intercept (HK) reduced its iRadimed (IRMD) stake by 40% in Q3 2026, selling an estimated $849K and leaving 14,171 shares worth $1.22M. The position accounts for 0.03% of the portfolio, ranked #900.

Y-Intercept (HK) first reported a position in IRMD in Q2 2024 and has held it in 4 quarters since. The position peaked at $2.26M in Q2 2026. 18 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • Y-Intercept (HK) held 14,171 shares of iRadimed worth $1.22M as of Q3 2026.
  • Y-Intercept (HK) sold 9,446 iRadimed shares in Q3 2026, an estimated $849K.
  • iRadimed made up 0.03% of Y-Intercept (HK)'s portfolio in Q3 2026, its #900 holding.
  • Y-Intercept (HK) first reported a position in iRadimed in Q2 2024 and has held it in 4 quarters since.
  • Y-Intercept (HK)'s iRadimed position peaked at $2.26M in Q2 2026.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.